Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;17(10):618-634.
doi: 10.1038/s41575-020-0296-6. Epub 2020 May 28.

The evolution and clinical impact of hepatitis B virus genome diversity

Peter A Revill  1   2 , Thomas Tu  3   4   5 , Hans J Netter  1 , Lilly K W Yuen  1 , Stephen A Locarnini  1 , Margaret Littlejohn  6   7
Affiliations
Review

The evolution and clinical impact of hepatitis B virus genome diversity

Peter A Revill et al. Nat Rev Gastroenterol Hepatol. 2020 Oct.

Abstract

The global burden of hepatitis B virus (HBV) is enormous, with 257 million persons chronically infected, resulting in more than 880,000 deaths per year worldwide. HBV exists as nine different genotypes, which differ in disease progression, natural history and response to therapy. HBV is an ancient virus, with the latest reports greatly expanding the host range of the Hepadnaviridae (to include fish and reptiles) and casting new light on the origins and evolution of this viral family. Although there is an effective preventive vaccine, there is no cure for chronic hepatitis B, largely owing to the persistence of a viral minichromosome that is not targeted by current therapies. HBV persistence is also facilitated through aberrant host immune responses, possibly due to the diverse intra-host viral populations that can respond to host-mounted and therapeutic selection pressures. This Review summarizes current knowledge on the influence of HBV diversity on disease progression and treatment response and the potential effect on new HBV therapies in the pipeline. The mechanisms by which HBV diversity can occur both within the individual host and at a population level are also discussed.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol. Hepatol. 3, 383–403 (2018).
    1. World Health Organization. Global Hepatitis Report, 2019 https://www.who.int/hepatitis/publications/global-hepatitis-report2017/en/ (WHO, 2017).
    1. Parkin, D. M. Global cancer statistics in the year 2000. Lancet Oncol. 2, 533–543 (2001). - PubMed
    1. Revill, P. A. et al. A global scientific strategy to cure hepatitis B. Lancet Gastroenterol. Hepatol. 4, 545–558 (2019). - PubMed - PMC
    1. Alter, H. et al. A research agenda for curing chronic hepatitis B virus infection. Hepatology 67, 1127–1131 (2018). - PubMed - PMC

Publication types

Substances

LinkOut - more resources